These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
210 related items for PubMed ID: 17060898
1. Update: Guillain-Barré syndrome among recipients of Menactra meningococcal conjugate vaccine--United States, June 2005-September 2006. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2006 Oct 20; 55(41):1120-4. PubMed ID: 17060898 [Abstract] [Full Text] [Related]
6. Guillain-Barré syndrome after vaccination in United States: data from the Centers for Disease Control and Prevention/Food and Drug Administration Vaccine Adverse Event Reporting System (1990-2005). Souayah N, Nasar A, Suri MF, Qureshi AI. J Clin Neuromuscul Dis; 2009 Sep 14; 11(1):1-6. PubMed ID: 19730016 [Abstract] [Full Text] [Related]
8. Phase III comparison of an investigational quadrivalent meningococcal conjugate vaccine with the licensed meningococcal ACWY conjugate vaccine in adolescents. Jackson LA, Baxter R, Reisinger K, Karsten A, Shah J, Bedell L, Dull PM, V59P13 Study Group. Clin Infect Dis; 2009 Jul 01; 49(1):e1-10. PubMed ID: 19476428 [Abstract] [Full Text] [Related]
9. Use of meningococcal vaccines in the United States. Bilukha O, Messonnier N, Fischer M. Pediatr Infect Dis J; 2007 May 01; 26(5):371-6. PubMed ID: 17468644 [Abstract] [Full Text] [Related]
10. Guillain-Barre syndrome after vaccination in United States a report from the CDC/FDA Vaccine Adverse Event Reporting System. Souayah N, Nasar A, Suri MF, Qureshi AI. Vaccine; 2007 Jul 20; 25(29):5253-5. PubMed ID: 17560693 [Abstract] [Full Text] [Related]
11. Guillain-Barre syndrome among recipients of Menactra meningococcal conjugate vaccine. Ann Pharmacother; 2006 May 20; 40(5):1007. PubMed ID: 16670362 [No Abstract] [Full Text] [Related]
13. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2010 Jun 04; 59(21):657-61. PubMed ID: 20520590 [Abstract] [Full Text] [Related]
14. Risk of Guillain-Barré syndrome following serogroup C meningococcal conjugate vaccine in Quebec, Canada. De Wals P, Deceuninck G, Boucher RM, Ouakki M. Clin Infect Dis; 2008 Apr 15; 46(8):e75-7. PubMed ID: 18444843 [Abstract] [Full Text] [Related]
16. Adverse events following quadrivalent meningococcal diphtheria toxoid conjugate vaccine (Menactra®) reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2016. Myers TR, McNeil MM, Ng CS, Li R, Marquez PL, Moro PL, Omer SB, Cano MV. Vaccine; 2020 Sep 11; 38(40):6291-6298. PubMed ID: 32747215 [Abstract] [Full Text] [Related]
17. Guillain-Barré syndrome after Gardasil vaccination: data from Vaccine Adverse Event Reporting System 2006-2009. Souayah N, Michas-Martin PA, Nasar A, Krivitskaya N, Yacoub HA, Khan H, Qureshi AI. Vaccine; 2011 Jan 29; 29(5):886-9. PubMed ID: 20869467 [Abstract] [Full Text] [Related]
18. Guillain-Barré syndrome after influenza vaccination in the United States, a report from the CDC/FDA vaccine adverse event reporting system (1990-2009). Souayah N, Yacoub HA, Khan HM, Farhad K, Mehyar LS, Maybodi L, Menkes DL, Qureshi AI. J Clin Neuromuscul Dis; 2012 Dec 29; 14(2):66-71. PubMed ID: 23172385 [Abstract] [Full Text] [Related]